| Literature DB >> 27488054 |
Moniba Sajid1, Muhammad Rashid Khan2, Naseer Ali Shah3, Sayed Afzal Shah4, Hammad Ismail5, Tahira Younis1, Zartash Zahra1.
Abstract
BACKGROUND: Alnus nitida (Spach) Endl. is traditionally used for inflammatory disorders. Diarylheptanoids constituents having diverse therapeutically importance including hepato-protective was reported in A. nitida. The aim of this study was to explore the antioxidant and hepato-protective profile of A. nitida stem bark's crude methanol extract (ANM).Entities:
Keywords: Alnus nitida; Antioxidant; Flavonoids; HPLC; Hepatoprotective; Phenolics
Mesh:
Substances:
Year: 2016 PMID: 27488054 PMCID: PMC4972964 DOI: 10.1186/s12906-016-1245-3
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Phytochemical analysis of A. nitida bark methanol extract and derived fractions
| Compound class | Extract/Fraction | ||||
|---|---|---|---|---|---|
| ANM | ANH | ANC | ANE | ANA | |
| Alkaloids | + | - | - | + | + |
| Anthraquinones | + | + | + | + | - |
| Tannins | + | - | + | - | + |
| Terpenoids | + | + | + | + | + |
| Saponins | + | - | + | - | + |
| Betacyanin | + | - | - | - | - |
| Coumarins | + | - | + | + | + |
| Flavonoids | + | - | + | + | + |
| Phenols | + | - | + | + | + |
(+) present, (−) absent
ANM A. nitida methanol extract, ANH A. nitida n-hexane fraction, ANC A. nitida chloroform fraction, ANE A. nitida ethyl acetate fraction, ANA A. nitida aqueous fraction
Estimation of plant extraction yield, total phenolics, flavonoids, antioxidant capacity and reducing power of Alnus nitida bark
| Sample | Yield (g)* | Total phenolic contents expressed as gallic acid equivalents (mg/g of extract) | Total flavonoid contents expressed as rutin equivalents (mg/g of extract) | Total antioxidant capacity expressed as ascorbic acid equivalents (mg/g of extract) | Total reducing power expressed as ascorbic acid equivalents (mg/g of extract) |
|---|---|---|---|---|---|
| ANM | 86 | 631.5 ± 1.7 | 221.5 ± 2.5 | 32.6 ± 1.2a | 125.5 ± 5.0a,b |
| ANH | 7 | 0.00 | 0.00 | 3.5 ± 0.5c | 36.0 ± 2.6d |
| ANC | 24 | 527 ± 3.1 | 98.6 ± 1.61 | 7.6 ± 0.9c | 45.5 ± 3.3d |
| ANE | 21 | 607 ± 1.97 | 211.2 ± 2.4 | 19.0 ± 0.6b | 113.1 ± 2.7b,c |
| ANA | 33 | 591.2 ± 1.3 | 114.8 ± 1.8 | 16.5 ± 1.1b | 102.0 ± 3.3c |
Values are presented as mean ± SD (n = 3). Means with different superscript (a–f) letters in column are significantly (P < 0.01) different from each other. * Yield of ANM is based on the dry powder; the yield of its fractions is based on the yield of ANM
ANM A. nitida methanol extract, ANH A. nitida n-hexane fraction, ANC A. nitida chloroform fraction, ANE A. nitida ethyl acetate fraction, ANA A. nitida aqueous fraction
HPLC-DAD profile of A. nitida bark methanol extract, ANE and ANA
| Extract | Polyphenolics (μg/g of extract) | |||||||
|---|---|---|---|---|---|---|---|---|
| Rutin | Gallic acid | Catechin | Caffeic acid | Apigenin | Kaempferol | Quercetin | Myricetin | |
| ANM | 203 | 234 | 233 | - | - | - | - | - |
| ANE | - | 270 | - | - | - | - | - | - |
| ANA | 1659 | 550 | 2326 | - | - | - | - | - |
ANM A. nitida methanol extract, ANH A. nitida n-hexane fraction, ANC A. nitida chloroform fraction, ANE A. nitida ethyl acetate fraction, ANA A. nitida aqueous fraction
Fig. 1HPLC-DAD chromatogram of ANM (a) and ANA (b) at different wavelengths Signal 1: 257λ, Signal 2:279λ. Conditions: Mobile Phase A-ACN: MEOH: H2O: AA:: 5:10:85:1, Mobile phase B-ACN: MEOH: AA:: 40:60:1, Injection volume 20 μL, Flow rate 1 ml/min, Agilent RP-C8
IC50 values of different antioxidant activities of ANM and its fractions
| IC50 (μg/ml) | |||||
|---|---|---|---|---|---|
| Sample | DPPH scavenging | Hydroxyl scavenging | Nitric oxide scavenging activity | β-carotene bleaching scavenging activity | Iron chelating assay |
| ANM | 32.0 ± 1.8d | 97.5 ± 2.9d | 153.6 ± 4.0c | 103.6 ± 4.2c | 130.5 ± 4.1c |
| ANH | 951.5 ± 4.3a | 932.5 ± 3.3a | 465.5 ± 2.8a | 858.9 ± 3.8a | 430.2 ± 3.9a |
| ANC | 633.8 ± 3.9b | 812.5 ± 2.9b | 414.9 ± 2.8b | 726.2 ± 4.7b | 347.9 ± 2.2b |
| ANE | 39.5 ± 2.1c,d | 102.7 ± 3.3d | 151.8 ± 3.1c | 41.4 ± 1.9f | 130.1 ± 0.8c |
| ANA | 43.7 ± 2.9c | 173.4 ± 2.0c | 84.6 ± 3.7d | 54.7 ± 4.4e | 76.8 ± 4.5d |
| Rutin | - | 83.3 ± 4.2e | - | - | - |
| Ascorbic acid | 11.9 ± 0.5e | - | 56.9 ± 2.5e | - | - |
| EDTA | - | - | - | - | 56.0 ± 1.7e |
| Catechin | - | - | - | 90.2 ± 2.3d | - |
Values are presented as mean ± SD (n = 3). Means with different superscript (a–f) letters in the rows are significantly (P < 0.01) different from each other
ANM A. nitida methanol extract, ANH A. nitida n-hexane fraction, ANC A. nitida chloroform fraction, ANE A. nitida ethyl acetate fraction, ANA A. nitida aqueous fraction
Fig. 2Effect of different concentrations of MBM and its fractions on various in vitro antioxidant assays
Correlation of IC50 values of different antioxidant activities with total phenolic and total flavonoid contents
| Activity | Correlation R2 | |
|---|---|---|
| TFC | TPC | |
| DPPH scavenging activity | 0.91** | 0.86* |
| Nitric oxide scavenging activity | 0.55 | 0.77* |
| Hydroxyl radical scavenging activity | 0.75* | 0.84* |
| β-carotene bleaching scavenging activity | 0.68* | 0.82* |
| Iron chelating assay | 0.85* | 0.83* |
| Total antioxidant activity | 0.79* | 0.74* |
| Total reducing power Assay | 0.80* | 0.83* |
TFC total flavonoid content, TPC total phenolic content
Column with different superscripts are significantly different *, **, indicate P < 0.05, P < 0.01
Effect of different treatments of ANM on liver serum markers profile
| Group | ALT (U/l) | AST (U/l) | ALP (U/l) | Bilirubin |
|---|---|---|---|---|
| Control | 45.0 ± 1.56e | 40.3 ± 1.53e | 63.7 ± 1.10d | 0.59 ± 0.02d,e |
| Vehicle control | 40.8 ± 1.18e | 39.4 ± 1.18e | 60.4 ± 1.13d | 0.61 ± 0.02d,e |
| CCl4 (1 ml/kg) | 490.4 ± 5.19a | 320.9 ± 3.68a | 298.3 ± 3.29a | 1.97 ± 0.01c |
| Silymarin + CCl4 | 96.7 ± 2.47d | 96.9 ± 2.31d | 108.2 ± 3.98c | 0.73 ± 0.01c |
| ANM (200 mg/kg) + CCl4 | 137.2 ± 2.13b | 166.8 ± 2.06b | 196.7 ± 3.68b | 1.02 ± 0.10b |
| ANM (400 mg/kg) + CCl4 | 101.4 ± 1.74c | 121.4 ± 2.74c | 168.6 ± 2.61c | 0.66 ± 0.08c,d |
| ANM (200 mg/kg) | 52.0 ± 3.99c,d | 51.7 ± 2.81d | 73.9 ± 2.75c | 0.60 ± 0.03d,e |
| ANM (400 mg/kg) | 41.24 ± 2.01e | 37.2 ± 1.01e | 62.2 ± 2.70d | 0.59 ± 0.01e |
Values expressed as means ± SD. Means ± SD with different superscript letter (a–e) within the column indicate significant difference (P < 0.01)
Effect of different treatments of ANM on lipid profile
| Group | Triglycerides (mg/dl) | Total cholesterol (mg/dl) | HDL (mg/dl) | LDL (mg/dl) |
|---|---|---|---|---|
| Control | 83.6 ± 2.64e | 99.4 ± 2.22f | 46.1 ± 1.66e | 32.1 ± 1.28d,e |
| Vehicle control | 89.5 ± 2.19e | 90.3 ± 2.48f | 43.14 ± 1.70e | 30.4 ± 1.39e |
| CCl4 (1 ml/kg) | 372.0 ± 5.63a | 478.4 ± 5.96a | 19.2 ± 1.02a | 208.9 ± 2.89a |
| Silymarin + CCl4 | 120.8 ± 2.44d | 162.0 ± 2.26d | 40.0 ± 3.00e | 43.4 ± 1.55c |
| ANM (200 mg/kg) + CCl4 | 132.8 ± 2.63b | 187.8 ± 2.63b | 39.3 ± 2.28c | 44.1 ± 2.02b |
| ANM (400 mg/kg) + CCl4 | 124.1 ± 2.54c | 152.1 ± 2.54c | 41.19 ± 3.96d | 40.02 ± 1.8b |
| ANM (200 mg/kg) | 99.0 ± 3.98c,d | 92.3 ± 2.98e | 43.0 ± 2.98e | 38.0 ± 1.98c |
| ANM (400 mg/kg) | 86.7 ± 1.43e | 87.2 ± 2.42f | 47.4 ± 1.15f | 35.1 ± 1.38d |
Values expressed as means ± SD. Means ± SD with different superscript letter (a–f) within the column indicate significant difference (P < 0.01)
Effect of different treatments of A. nitida stem bark crude extract on liver tissue protein, TBARS, H2O2, nitrite and GSH content
| Group | Protein (μg/mg tissue) | TBARS (nM/min/mg) | H2O2 (nM/min/mg tissue) | Nitrite content ( μM/ml) | GSH (μM/g tissue) |
|---|---|---|---|---|---|
| Control | 6.41 ± 0.23a | 1.52 ± 0.08d | 6.38 ± 0.15g | 61.5 ± 1.78d | 47.0 ± 2.84a |
| Vehicle control | 6.14 ± 0.20a | 1.73 ± 0.07c,d | 6.77 ± 0.16g | 64.2 ± 2.83d | 45.65 ± 2.2a |
| CCl4 (1 ml/kg) | 3.98 ± 0.16e | 5.32 ± 0.06a | 18.3 ± 0.26a | 106.3 ± 4.67a | 12.6 ± 1.23d |
| Silymarin + CCl4 | 5.16 ± 0.19b | 2.11 ± 0.08b | 8.37 ± 0.15e | 70.4 ± 0.27c | 46.7 ± 1.77a |
| ANM (200 mg/kg) + CCl4 | 4.42 ± 0.14d | 2.11 ± 0.06b | 12.2 ± 0.21b | 90.2 ± 2.26b | 30.74 ± 1.95c |
| ANM (400 mg/kg) + CCl4 | 5.02 ± 0.14c | 2.02 ± 0.06b,c | 11.1 ± 0.14c | 71.1 ± 1.27c | 41.3 ± 1.68b |
| ANM (200 mg/kg) | 5.90 ± 0.16b,c | 1.81 ± 0.39b | 7.92 ± 0.29d | 61.9 ± 2.75c | 45.4 ± 1.48a,b |
| ANM (400 mg/kg) | 6.48 ± 0.32a | 1.51 ± 0.16d | 7.50 ± 0.29f | 60.0 ± 2.45d | 49.1 ± 1.84a |
Values expressed as means ± SD. Means ± SD with different superscript letter (a–g) within the column indicate significant difference (P < 0.01)
Effect of different treatments of A. nitida stem bark crude extract on liver tissues antioxidant enzymes
| Group | CAT (U/min) | POD (U/min) | SOD (U/mg protein) | GST (nM/min/mg protein) | GPx (nM/min/mg protein) | GR (nM/min/mg protein) |
|---|---|---|---|---|---|---|
| Control | 6.68 ± 0.10a | 10.39 ± 0.22a | 5.54 ± 0.36a | 139.8 ± 3.22a | 92.8 ± 2.05a | 137.2 ± 2.51a |
| Vehicle control | 6.35 ± 0.39a | 10.06 ± 0.43a | 5.05 ± 0.62a | 139.05 ± 3.50a | 93.3 ± 1.27a | 133.1 ± 3.51b |
| CCl4 (1 ml/kg) | 3.49 ± 0.09e | 5.82 ± 0.12e | 2.49 ± 0.29c | 53.77 ± 1.61e | 32.9 ± 1.79f | 61.2 ± 1.33f |
| Silymarin + CCl4 | 5.29 ± 0.11c | 8.57 ± 0.29b | 4.65 ± 0.32ab | 122.5 ± 2.41b | 82.8 ± 1.74d | 114.5 ± 2.58d |
| ANM (200 mg/kg) + CCl4 | 4.30 ± 0.15d | 6.20 ± 0.31d | 3.67 ± 0.27b | 82.63 ± 1.61d | 62.4 ± 1.77e | 86.0 ± 3.05e |
| ANM (400 mg/kg) + CCl4 | 5.61 ± 0.19bc | 7.57 ± 0.33d | 4.61 ± 0.29a,b | 103.8 ± 2.97c | 85.9 ± 1.48c,d | 119.19 ± 2.5c |
| ANM (200 mg/kg) | 6.19 ± 0.20b | 9.99 ± 0.24c | 4.84 ± 0.36a,b | 140.0 ± 3.18b | 90.9 ± 2.82b,c | 125.1 ± 3.31b |
| ANM (400 mg/kg) | 6.53 ± 0.28a | 10.14 ± 0.21b | 5.73 ± 0.26a | 141.3 ± 2.77a | 91.0 ± 0.91a,b | 136.2 ± 3.02a |
Values expressed as means ± SD. Means ± SD with different superscript letter (a–f) within the column indicate significant difference (P < 0.01)
Fig. 3Protective outcome of ANM on histology of hepatic tissues (40× magnification). a Control group b Vehicle group c CCl4 1 m/kg bw, i.p., 30 % in olive oil group, d CCl4 + Silymarin 200 mg/kg bw group, e CCl4 + Crude extract 200 mg/kg bw group, f CCl4 + Crude extract 400 mg/kg bw group, g Crude extract 200 mg/kg bw group, h Crude extract 400 mg/kg bw group. CV; Central venule, PV; portal vein, HPC; Hepatocytes, S; Sinusoides, DLS; Degeneration of lobular shape, FC; Fatty change, and MCI; Monocyte nuclear cell infiltration